CalciMedica, Inc.
General ticker "CALC" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $42.8M (TTM average)
CalciMedica, Inc. follows the US Stock Market performance with the rate: 29.6%.
Estimated limits based on current volatility of 1.1%: low 0.54$, high 0.64$
Factors to consider:
- Total employees count: 14 as of 2024
- Current price 68.1% below estimated low
- Earnings for 9 months up through Q3 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-12-31 to 2026-12-31
- 2024-12-31 to 2025-12-31 estimated range: [1.78$, 4.87$]
- 2025-12-31 to 2026-12-31 estimated range: [1.69$, 4.54$]
Short-term CALC quotes
Long-term CALC plot with estimates
Financial data
| YTD | 2023-12-31 | 2024-12-31 |
|---|---|---|
| Operating Revenue | $0.00MM | $0.00MM |
| Operating Expenses | $38.08MM | $24.20MM |
| Operating Income | $-38.08MM | $-24.20MM |
| Non-Operating Income | $3.72MM | $10.50MM |
| Interest Expense | $0.11MM | $0.00MM |
| R&D Expense | $15.86MM | $14.48MM |
| Income(Loss) | $-34.36MM | $-13.70MM |
| Profit(Loss)* | $-34.36MM | $-13.70MM |
| Stockholders Equity | $8.16MM | $14.41MM |
| Assets | $12.19MM | $19.79MM |
| Operating Cash Flow | $-25.73MM | $-21.15MM |
| Capital expenditure | $0.08MM | $0.01MM |
| Investing Cash Flow | $8.88MM | $-4.42MM |
| Financing Cash Flow | $20.90MM | $27.97MM |
| Earnings Per Share** | $-7.65 | $-1.22 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.